HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Kyu Lee Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

5/2019Progression of Multifaceted Immune Cells in Atherosclerotic Development.
3/2007Effects of PGC-1alpha on TNF-alpha-induced MCP-1 and VCAM-1 expression and NF-kappaB activation in human aortic smooth muscle and endothelial cells.
5/2004Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


In-Kyu Lee Research Topics

Disease

40Type 2 Diabetes Mellitus (MODY)
05/2024 - 07/2002
32Inflammation (Inflammations)
02/2024 - 05/2004
32Neoplasms (Cancer)
11/2022 - 02/2008
25Obesity
01/2024 - 07/2004
24Insulin Resistance
04/2024 - 03/2007
18Atherosclerosis
03/2022 - 05/2004
17Fibrosis (Cirrhosis)
01/2024 - 03/2004
14Mitochondrial Diseases (Mitochondrial Disease)
10/2023 - 02/2012
12Fatty Liver
10/2023 - 09/2009
11Vascular Calcification
01/2023 - 04/2010
11Body Weight (Weight, Body)
12/2022 - 03/2004
11Cardiovascular Diseases (Cardiovascular Disease)
03/2022 - 12/2005
10Hypoxia (Hypoxemia)
02/2024 - 10/2008
10Metabolic Diseases (Metabolic Disease)
10/2023 - 04/2010
10Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2017 - 09/2009
8Hyperglycemia
01/2023 - 02/2007
7Hyperplasia
10/2015 - 11/2006
6Non-alcoholic Fatty Liver Disease
11/2023 - 12/2010
6Hepatocellular Carcinoma (Hepatoma)
11/2022 - 02/2010
6Ototoxicity
01/2022 - 06/2014
6Vascular System Injuries
03/2015 - 06/2002
5Acute Kidney Injury (Acute Renal Failure)
02/2024 - 01/2017
5Anaplastic Thyroid Carcinoma
01/2021 - 11/2015
5Thrombosis (Thrombus)
05/2019 - 10/2009
4Ischemia
02/2024 - 03/2016
4Hearing Loss (Hearing Impairment)
06/2020 - 06/2014
4Hypersensitivity (Allergy)
01/2019 - 10/2015
4Hyperlipidemias (Hyperlipidemia)
01/2019 - 09/2009
4Neuroinflammatory Diseases
01/2019 - 02/2015
4Vascular Remodeling
10/2015 - 12/2005
4Hypertension (High Blood Pressure)
02/2014 - 01/2011
3Reperfusion Injury
02/2024 - 01/2017
3Liver Cirrhosis (Hepatic Cirrhosis)
11/2023 - 03/2010
3Nervous System Diseases (Neurological Disorders)
01/2022 - 09/2016
3Diabetic Neuropathies (Diabetic Neuropathy)
01/2021 - 03/2016
3Bone Resorption
01/2021 - 11/2012
3Thyroid Neoplasms (Thyroid Cancer)
11/2020 - 07/2012

Drug/Important Bio-Agent (IBA)

27Glucose (Dextrose)FDA LinkGeneric
05/2024 - 07/2002
24Proteins (Proteins, Gene)FDA Link
04/2024 - 09/2009
15Oxidoreductases (Dehydrogenase)IBA
01/2021 - 04/2009
13Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 03/2007
13AntioxidantsIBA
11/2023 - 02/2003
12pyruvate dehydrogenase kinase 4IBA
02/2024 - 01/2012
12Pyruvic Acid (Pyruvate)IBA
05/2023 - 11/2012
12LipidsIBA
01/2023 - 02/2003
12Estrogens (Estrogen)FDA Link
11/2022 - 01/2012
11Insulin (Novolin)FDA Link
01/2021 - 09/2009
11Thioctic Acid (Lipoic Acid)IBA
12/2014 - 07/2004
10Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2023 - 06/2014
9Phosphotransferases (Kinase)IBA
11/2022 - 08/2011
9CytokinesIBA
01/2022 - 11/2006
8Orphan Nuclear ReceptorsIBA
11/2022 - 02/2007
7CalciumIBA
01/2023 - 01/2013
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2012
7EnzymesIBA
01/2022 - 07/2004
7GSK5182IBA
12/2019 - 01/2012
7Plasminogen Activator Inhibitor 1IBA
01/2012 - 09/2009
6Metformin (Glucophage)FDA LinkGeneric
05/2024 - 02/2008
6AMP-Activated Protein KinasesIBA
11/2023 - 07/2004
6Lactic Acid (Lactate)FDA LinkGeneric
05/2021 - 10/2015
6Therapeutic UsesIBA
01/2021 - 11/2013
6Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 02/2008
6ClusterinIBA
01/2018 - 10/2009
5Choline (Choline Chloride)IBA
01/2024 - 09/2009
5Methionine (L-Methionine)FDA Link
11/2023 - 09/2009
5Hormones (Hormone)IBA
01/2022 - 01/2012
5Oxygen (Dioxygen)IBA
11/2021 - 10/2008
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 01/2012
4Fatty Acids (Saturated Fatty Acids)IBA
04/2024 - 04/2012
4Phosphates (Orthophosphate)IBA
01/2023 - 02/2012
4fibroblast growth factor 21IBA
11/2022 - 08/2014
4NAD (NADH)IBA
01/2021 - 04/2009
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 01/2013
4sodium-iodide symporter (sodium iodide symporter)IBA
01/2019 - 11/2015
4Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
10/2016 - 02/2012
4Messenger RNA (mRNA)IBA
05/2015 - 09/2009
4Fibronectins (Fibronectin)IBA
07/2014 - 10/2009
4quinone (benzoquinone)IBA
02/2014 - 04/2009
4Collagen Type I (Type I Collagen)IBA
02/2012 - 10/2009
4Transforming Growth Factor beta (TGF-beta)IBA
03/2010 - 03/2004
4NF-kappa B (NF-kB)IBA
03/2007 - 11/2006
3Tryptophan HydroxylaseIBA
10/2023 - 01/2021
3Sirtuin 1IBA
01/2023 - 02/2014
3GlucocorticoidsIBA
12/2022 - 01/2011
3IronIBA
01/2022 - 05/2006
3Persistent Organic PollutantsIBA
01/2022 - 03/2007
3Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 12/2013
3TunicamycinIBA
01/2021 - 02/2010
3GoldIBA
01/2021 - 01/2017
3Lipocalin-2IBA
01/2021 - 01/2019
3AcidsIBA
01/2021 - 01/2016
3Glutamine (L-Glutamine)FDA Link
11/2020 - 03/2015
3Sterol Regulatory Element Binding Protein 1IBA
12/2019 - 05/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2019 - 05/2004
3LigandsIBA
01/2019 - 06/2007

Therapy/Procedure

22Therapeutics
05/2024 - 10/2008
5Glycemic Control
10/2021 - 01/2015
3Precision Medicine
01/2022 - 10/2015
3Drug Therapy (Chemotherapy)
05/2021 - 11/2012
3Stents
11/2020 - 12/2009